Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Zeng-Chen Ma"'
Autor:
Ning-lin Ge, Jinglin Xia, Yu-Hong Gan, Zhao-You Tang, Bing-Hui Yang, Sheng-Long Ye, Zeng-Chen Ma, Xin-Da Zhou, Zhiying Lin, Zhenggang Ren, Dilip Sharma, Jia Fan, Zhi-Quan Wu, Lun-Xiu Qin, Yi Chen
Publikováno v:
European Journal of Radiology. 59:407-412
Objective To study severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Methods Clinical records of severe and rare complications following TACE in 1348 cases of liver cancer from January 1997 to February 2004 wer
Autor:
Hui-Chuan Sun, Yong-Bin Qian, Yue-Fang Shen, Xin-Da Zhou, Jia Fan, Zhao-You Tang, Jian Zhou, Shuang-Jian Qiu, Zeng-Chen Ma, Bo-Heng Zhang, Qin-Hai Ye, Lu Wang, Zhi-Quan Wu, Lun-Xiu Qin
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 132:458-465
Background/Aims: Recurrence after resection of hepatocellular carcinoma (HCC) is a frequent event. This study evaluated the effect of postoperative interferon α (IFN α) treatment on recurrence and survival in patients with hepatitis B virus (HBV)-r
Autor:
Zeng-Chen Ma, Li-wen Huang, Zhenggang Ren, Lun-Xiu Qin, Jinglin Xia, Zhi-Quan Wu, Xin-Da Zhou, Qing-Hai Ye, Zhao-You Tang, Zhiying Lin, Hui-Chuan Sun, Jia Fan
Publikováno v:
Chinese Journal of Clinical Oncology. 2:820-823
Objective The present study was designed to develop the “Three-Grade Criteria” for radical resection of primary liver cancer (PLC) and to evaluate its clinical significance.
Autor:
Xue-Ning Ji, Qin-Hai Ye, Shuang-Jian Qiu, Zeng-Chen Ma, Jian Zhou, Hui-Chuan Sun, Zhao-You Tang, Jia Fan, Lu Wang, Xin-Da Zhou, Zhi-Quan Wu, Lun-Xiu Qin, Jing-Ling Xia, Hu Liu, Kang-Da Liu, Sheng-Long Ye, Yinkun Liu, Zhi-Ying Lin, Yan Li
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 130:187-196
Metastasis remains one of the major challenges before hepatocellular carcinoma (HCC) is finally conquered. This paper summarized a decade's studies on HCC metastasis at the Liver Cancer Institute of Fudan University. We have established a stepwise me
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 129:543-548
Large primary liver cancer (PLC) more than 10 cm in diameter is not infrequently encountered in clinical practice. This study evaluated the clinicopathological features and long-term results after surgery for large PLC.Comparison of clinicopathologic
Autor:
Yin Kun Liu, Qing Hai Ye, Zhao-You Tang, Yi Chen, Richard M. Simon, Sheng Long Ye, Xin Wei Wang, Ana I. Robles, Ping He, Marshonna Forgues, Zhi Quan Wu, Yan Li, Amy C. Peng, Jin Woo Kim, Zeng Chen Ma, Lun Xiu Qin
Publikováno v:
Nature Medicine. 9:416-423
Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Its high mortality rate is mainly a result of intra-hepatic metastases. We analyzed the expression profiles of HCC samples without or with intra-hepatic metas
Autor:
Sheng-Long Ye, Yinkun Liu, F. X. Sun, Zhonghao Tang, Svetlana Pack, Z. Y. Lin, Zhi-Quan Wu, Zhengping Zhuang, Xin Yuan Guan, Jie Tian, Xu Dong Zhou, Lun-Xiu Qin, Zeng-Chen Ma
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 127:482-488
Recently, we found that chromosome 8p deletion might be associated with hepatocellular carcinoma (HCC) metastasis by analyzing the differences in chromosomal alterations between primary tumors and their matched metastatic lesions of HCC with comparat
Autor:
Zhi-Quan Wu, Sheng-Long Ye, Jia Fan, Bo-Heng Zheng, Zhi-Ying Lin, Lun-Xiu Qin, Xin-Da Zhou, Bing-Hui Yang, Zeng-Chen Ma, Zhao-You Tang
Publikováno v:
Cancer. 91:1479-1486
BACKGROUND Recently, the implementation of screening programs using α-fetoprotein (AFP) and ultrasonography in high risk populations has identified increasing numbers of patients with small hepatocellular carcinoma (small HCC). The aim of this study
Autor:
Jian-Hua Wang, Zhao-Chong Zeng, Zhi-Quan Wu, Jian Zhou, Chi-Sheng Zhong, Zeng-Chen Ma, Lun-Xiu Qin, Zhao-You Tang, Jia Fan, Bin-Liang Wang
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 23:449-454
Surgical resection has been accepted as the only curative therapy for primary liver cancer (PLC). Unfortunately, most patients are surgically unresectable when they seek treatment. An alternative therapeutic approach for some of these patients is tra
Autor:
Jia Fan, Sheng-Long Ye, Xin-Da Zhou, Zhi-Quan Wu, Zhao-You Tang, Zeng-Chen Ma, Ji-Zhen Lu, Kang-Da Liu, Bing-Hui Yang, Zhi-Ying Lin
Publikováno v:
Journal of Gastroenterology and Hepatology. 13:S315-S319
By 1996, 2898 patients with pathologically proven hepatocellular carcinoma (HCC) had been treated at the Liver Cancer Institute of Shanghai Medical University. The 5 year survival in the entire series was 36.2%, being increased from 4.8% in 1958-70,